Adial Pharma [ADIL] - Last Close: $0.2023
Adial Pharma investors are enjoying a much-needed rebound rally.
The company's shares are rallying after Nasdaq granted its request to extend the deadline to file its quarterly report until Aug. 21st, 2023.
Adial Pharma will be expected to publish financial results for the quarter ended June 30th by the deadline to avoid penalties.
The company also expects the quarterly report to include a plan to regain compliance with Nasdaq's minimum shareholder equity rules.
ADIL is up 23.5% on the news.
My Take: ADIL looks like it's in bad shape. There could be more opportunities for short-term pops in share prices in the weeks ahead, but I am bearish.
Crown Electrokinetics [CRKN] - Last Close: $0.102
Crown Electrokinetics is making big waves in today's premarket.
The high-tech materials firm published a Form 424B4 on Monday relating to an upcoming offering from certain selling shareholders.
Shares CRKN fell 13.5% on Monday following the report's release, but the stock is rebounding in today's premarket.
CRKN is up 27.3% ahead of today's open, and it's the premarket's most actively traded stock.
My Take: CRKN's sudden reversal could be a sign that the stock is approaching its bottom.
